SBIR Phase I- Topic 410 - Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement.
SBIR Phase I- Topic 410 - Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement.
批准号:
10265762
负责人:
Frank Manion
金额:
$40.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-16 至 2021-06-15
关键词:
AddressAuthorization documentationClinical TrialsCommunicationComprehensionConsent FormsGoalsGrantHealthInformed ConsentLanguageNatural Language ProcessingOntologyParticipantPersonal CommunicationPhaseProcessResearchSmall Business Innovation Research GrantTechnologyWorkbasecancer clinical trialimprovedinterestprototyperecruittooltool developmentuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Many clinical trials fail to meet their accrual and retention goals, which leads to delays,
early termination, or inability to draw conclusions at trial completion due to loss of
statistical power. NCI wants to enhance clinical trials recruitment and retention by
developing tools that could enhance communication between participants and study staff.
In this Phase 1 tool development application we address the NCI interest in simplified
informed consent documents that enhance personal communication during the informed
consent process. In this Phase I proposal we leverage natural language processing technology and our
teams prior work on the Informed Consent Ontology (ICO) to improve the language in
consent documents related specifically to permissions granted by a research participant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金